Results 11 to 20 of about 57,685 (203)
Colistin Resistance and Management of Drug Resistant Infections
Canadian Journal of Infectious Diseases and Medical Microbiology, 2022 Colistin resistance is a globalized sensible issue because it has been considered a drug of the last-line resort to treat drug-resistant bacterial infections.
Juhi Sharma +3 more
doaj +2 more sources
Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
Antibiotics, 2023 Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the treatment of infections caused by multidrug-resistant A.
K. Novović, B. Jovčić
semanticscholar +1 more source
Colistin: From the shadows to a One Health approach for addressing antimicrobial resistance.
International Journal of Antimicrobial Agents, 2023 Antimicrobial resistance (AMR) poses a serious threat to human, animal, and environmental health worldwide. Colistin has regained importance as a last-resort treatment against multidrug-resistant Gram-negative bacteria.
M. Rhouma, J. Madec, R. Laxminarayan
semanticscholar +1 more source
The Lancet Microbe, 2023 BACKGROUND The emergence of colistin-resistant Enterobacterales is a global public health concern, yet colistin is still widely used in animals that are used for food as treatment, metaphylaxis, prophylaxis, and growth promotion.
M. Umair +9 more
semanticscholar +1 more source
Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria
Frontiers in Medicine, 2021 Colistin regained global interest as a consequence of the rising prevalence of multidrug-resistant Gram-negative Enterobacteriaceae. In parallel, colistin-resistant bacteria emerged in response to the unregulated use of this antibiotic.
F. A. Gogry +3 more
semanticscholar +1 more source
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)
Emerging Microbes and Infections, 2020 Increasing antibiotic resistance in multidrug-resistant (MDR) Gram-negative bacteria (MDR-GNB) presents significant health problems worldwide, since the vital available and effective antibiotics, including; broad-spectrum penicillins, fluoroquinolones ...
Mohamed Abd El-Gawad El-Sayed Ahmed +5 more
semanticscholar +1 more source
Resolving colistin resistance and heteroresistance in Enterobacter species
Nature Communications, 2023 Taxonomical complexity has muddled the classification of clinically relevant Enterobacter species. Authors carry out a genome-based study on clinical isolates to investigate colistin resistance and heteroresistance in Enterobacter .
S. Doijad +27 more
semanticscholar +1 more source
Adsorption-desorption and degradation of colistin in soils under aerobic conditions
Ecotoxicology and Environmental Safety, 2022 Colistin has broad-spectrum activity against Gram-negative bacteria and has been considered as the last-resort treatment for multiantibiotic-resistant Gram-negative bacteria infections in human.
Lijuan Peng +3 more
doaj +1 more source
PLoS ONE, 2020 Long-term use of colistin for preventing Gram-negative bacterial infections in food animals was prohibited in Thailand in 2017, but it is permitted for short-term treatment.
Pariwat Poolperm +4 more
doaj +1 more source
Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin. [PDF]
PLoS ONE, 2018 BACKGROUND:Nephrotoxicity of intravenous (IV) colistin has impeded its clinical use; aerosolized (AS) colistin may be an alternative, but safety data are lacking. Therefore, this study aimed to evaluate the incidence of acute kidney injury (AKI) and risk
Kyoung Lok Min +5 more
doaj +1 more source